{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:08:31Z","timestamp":1787972911652,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.endien.2024.09.005","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T11:07:44Z","timestamp":1728126464000},"page":"355-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Executive summary of the Spanish consensus for the diagnosis, management, and follow-up of primary hyperaldosteronism"],"prefix":"10.1016","volume":"71","author":[{"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Parra Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia A.","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2024.09.005_bib0240","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2024.09.005_bib0245","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"Buffolo","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.endien.2024.09.005_bib0250","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.endien.2024.09.005_bib0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.endien.2024.09.005_bib0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fendo.2020.00121","article-title":"Long-term mortality for patients of primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"11","author":"Meng","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.endien.2024.09.005_bib0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.endien.2024.09.005_bib0270","first-page":"22","article-title":"Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: a meta-analysis","author":"Jing","year":"2021","journal-title":"J Renin\u2013Angiotensin\u2013Aldosterone Syst"},{"key":"10.1016\/j.endien.2024.09.005_bib0275","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.endien.2024.09.005_bib0280","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2024.09.005_bib0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.recesp.2012.07.025","article-title":"Hipertensi\u00f3n por hiperaldosteronismo: m\u00e1s lesi\u00f3n cardiaca, mayor riesgo cardiovascular","volume":"66","author":"Abad-Cardiel","year":"2013","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.endien.2024.09.005_bib0290","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2024.09.005_bib0295","doi-asserted-by":"crossref","first-page":"798364","DOI":"10.3389\/fcvm.2021.798364","article-title":"Cerebro-cardiovascular risk, target organ damage, and treatment outcomes in primary aldosteronism","volume":"8","author":"Lin","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.endien.2024.09.005_bib0300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cjca.2020.05.013","article-title":"Unilateral disease is common in patients with primary aldosteronism without adrenal nodules","volume":"37","author":"Sam","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.endien.2024.09.005_bib0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.endien.2024.09.005_bib0310","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-03773-9","article-title":"Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document","author":"Araujo-Castro","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.endien.2024.09.005_bib0315","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-03751-1","article-title":"Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism","author":"Araujo-Castro","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.endien.2024.09.005_bib0320","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0031-1295409","article-title":"Primary aldosteronism: who should be screened?","volume":"44","author":"Monticone","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.endien.2024.09.005_bib0325","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.endien.2024.09.005_bib0330","article-title":"Diagnosis of primary hyperaldosteronism","author":"Araujo-Castro","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.endien.2024.09.005_bib0335","first-page":"5","article-title":"The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism","author":"Rossi","year":"2020","journal-title":"Int J Cardiol Hypertens"},{"key":"10.1016\/j.endien.2024.09.005_bib0340","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"38","author":"Unger","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.endien.2024.09.005_bib0345","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism \u2013 the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.endien.2024.09.005_bib0350","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2024.09.005_bib0355","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-023-03573-7","article-title":"Epidemiology and diagnosis of primary aldosteronism. What have we learned from the SPAIN-ALDO registry?","author":"Araujo-Castro","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.endien.2024.09.005_bib0360","doi-asserted-by":"crossref","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.endien.2024.09.005_bib0365","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0034-1374638","article-title":"The role of urinary aldosterone for the diagnosis of primary aldosteronism","volume":"46","author":"Ceral","year":"2014","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.endien.2024.09.005_bib0370","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.endien.2024.09.005_bib0375","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.endien.2024.09.005_bib0380","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2024.09.005_bib0385","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/jhh.2016.7","article-title":"Decrease in serum potassium levels post saline suppression test in primary aldosteronism: an under-recognised phenomenon?","volume":"30","author":"Lee","year":"2016","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.endien.2024.09.005_bib0390","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.HYP.0000014324.68506.CA","article-title":"Diagnostic value of the post-captopril test in primary aldosteronism","volume":"39","author":"Castro","year":"2002","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.endien.2024.09.005_bib0395","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1515\/cclm-2015-1094","article-title":"Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension","volume":"54","author":"Rossi","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.endien.2024.09.005_bib0400","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"key":"10.1016\/j.endien.2024.09.005_bib0405","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.endien.2024.09.005_bib0410","first-page":"19","article-title":"The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population","author":"Zhu","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.endien.2024.09.005_bib0415","first-page":"14","article-title":"Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2-h sampling","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.endien.2024.09.005_bib0420","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cen.14134","article-title":"A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism","volume":"92","author":"Lin","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endien.2024.09.005_bib0425","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","article-title":"Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism","volume":"34","author":"Burrello","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.endien.2024.09.005_bib0430","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.endien.2024.09.005_bib0435","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.endien.2024.09.005_bib0440","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/cen.12761","article-title":"Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism","volume":"83","author":"Umakoshi","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endien.2024.09.005_bib0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecl.2019.08.012","article-title":"Adrenal venous sampling: where do we stand?","volume":"48","author":"Rossi","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endien.2024.09.005_bib0450","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/gs.2019.10.19","article-title":"Surgical approach to patients with primary aldosteronism","volume":"9","author":"Mcmanus","year":"2020","journal-title":"Gland Surg"},{"key":"10.1016\/j.endien.2024.09.005_bib0455","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12020-022-03029-4","article-title":"Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry","volume":"76","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.endien.2024.09.005_bib0460","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2024.09.005_bib0465","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.medcli.2020.04.029","article-title":"Treatment of primary hyperaldosteronism","volume":"155","author":"Araujo-Castro","year":"2020","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.endien.2024.09.005_bib0470","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-19-0215","article-title":"Therapy of endocrine disease: medical treatment of primary aldosteronism","volume":"181","author":"Lechner","year":"2019","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024000982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024000982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T11:38:19Z","timestamp":1728128299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018024000982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2530018024000982"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2024.09.005","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Executive summary of the Spanish consensus for the diagnosis, management, and follow-up of primary hyperaldosteronism","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2024.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}